GILD vs KNSL · P/E 18, rev $7.80B vs P/E 13, rev $1.02B
Gilead Sciences Inc (GILD) versus Kinsale Capital Group Inc (KNSL) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Kinsale Capital Group Inc (KNSL) is a insurance - property & casualty company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported KNSL revenue for 2026-06-30 was $1.02B. Net income was $288.4M. KNSL currently screens at market cap $7.06B and trailing P/E 13.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. KNSL currently screens at market cap $7.06B and trailing P/E 13.5.
Not investment advice. Open the GILD and KNSL stock pages for the full models.
Not investment advice.